Preliminary experience with nesiritide in pediatric patients less than 12 months of age

Journal of Intensive Care Medicine

Volumn 23, Issue 5, 2008, Pages 321-328

  Ryan, Angela ^a   Rosen, David A ^b   Tobias, Joseph D ^a,c  

^a University of Missouri   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Congenital heart disease; Congestive heart failure; Natriuretic peptide; Nesiritide

Indexed keywords

ADRENALIN; CREATININE; DOPAMINE; ELECTROLYTE; MILRINONE; NESIRITIDE;

ABSENCE OF SIDE EFFECTS; ARTICLE; BLOOD PRESSURE; CENTRAL VENOUS PRESSURE; DIURESIS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUID INTAKE; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; INFANT; LOADING DRUG DOSE; MALE; NEWBORN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

AGE FACTORS; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; INFANT; INFANT, NEWBORN; INTENSIVE CARE; MALE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR RESISTANCE; WATER-ELECTROLYTE IMBALANCE;

EID: 51849146288     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066608320840     Document Type: Article

References (24)

1. Marshall J., Berkenbosch JW, Russo P., Tobias JD Preliminary experience with nesiritide in the pediatric population. J Intensive Care Med. 2004 ; 19: 164-170.
2. Smith T., Rosen D., Russo P., et al. Nesiritide during extracorporeal membrane oxygenation. Paediatr Anaesth. 2005 ; 15: 152-157.
3. Wheeler A., Tobias JD Nesiritide in a pediatric oncology patient with renal insufficiency and myocardial dysfunction following septic shock. Pediatr Hematol Oncol. 2005 ; 22: 323-333.
4. Simsic JM, Scheurer M., Tobias JD, et al. Perioperative effects and safety of nesiritide following cardiac surgery in children. J Intensive Care Med. 2006 ; 21: 22-26.
5. Maisel AS, Krishnaswamy P., Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002 ; 347: 161-167.
6. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in evaluation and management of acute dyspnea. N Engl J Med. 2004 ; 350: 647-654.
7. Koulouri S., Acherman RJ, Wong PC, et al. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol. 2004 ; 25: 341-346.
8. Morimoto K., Mori T., Ishiguro S., et al. Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg Today. 1998 ; 28: 23-29.
9. Shih CY, Sapru A., Oishi P., et al. Alterations in b-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker. J Thorac Cardiovasc Surg. 2006 ; 131: 632-636.
10. Costello JM, Backer CL, Checchia PA, et al. Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure. Pediatr Cardiol. 2004 ; 25: 347-353.
11. Colucci WS, Elkayam U., Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med. 2000 ; 343: 246-253.
12. Publication Committee for VMAC Investigators. Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure. JAMA. 2002 ; 287: 1531-1540.
13. Marcus LS, Hart D., Packer M., et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 1996 ; 94: 3184-3189.
14. Francis GS, Siegel RM, Goldsmith SR, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Intern Med. 1985 ; 103: 1-6.
15. Gottlieb SS, Brater C., Thomas I. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002 ; 105: 1348.
16. Lombardi R., Ferreiro A., Servetto C. Renal function after cardiac surgery: adverse effect of furosemide. Ren Fail. 2003 ; 25: 775-786.
17. Jeffries JL, Denfield SW, Price JF, et. A prospective evaluation of nesiritide in the treatment of pediatric heart failure. Pediatr Cardiol. 2006 ; 27: 402-407.
18. Mahle WT, Cuadrado AR, Kirshbom PM, et al. Nesiritide in infants and children with congestive heart failure. Pediatr Crit Care Med. 2005 ; 6: 543-546.
19. Simsic JM, Reddy VS, Kanter KR, et al. Use of nesiritide (human b-type natriuretic peptide) in infants following cardiac surgery. Pediatr Cardiol. 2004 ; 25: 668-670.
20. Sehra R., Underwood K. Nesiritide use for critically ill children awaiting cardiac transplantation. Pediatr Cardiol. 2006 ; 27: 47-50.
21. Burger AJ, Horton DP, LeJemtel T., et al. Effect of nesiritide (b-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J. 2002 ; 144: 1102-1108.
22. Wang DJ, Dowling TC, Meadows D., et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation. 2004 ; 110: 1620-1625.
23. Sackner-Bernstein JD, Skopicki HA, Aaronson KD Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005 ; 111: 1487-1491.
24. Mentzer RM, Oz MC, Sladen RN, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA trial. J Am Coll Cardiol. 2007 ; 49: 716-726.